Bernhard S.
- Country
- Germany
- Department
- Onkologische Ambulanz
Research Overview
- Phase IIa Study of Durvalumab, Gemcitabine, Cisplatin, and Intraductal Radiofrequency Ablation in Extrahepatic Cholangiocarcinoma
- Evaluation of Adjuvant Therapy with Capecitabine in Stage II Colon and Rectal Cancer Patients with ctDNA Positivity Post-Resection
- Phase II Trial Comparing Trifluridine/Tipiracil with Panitumumab Versus Trifluridine/Tipiracil with Bevacizumab in Metastatic Colorectal Cancer
Data & Insights
Has run more than one trial at 89 of 218 partner sites.
Specializations
Colorectal Cancer Research
The investigator specializes in treating metastatic colorectal cancer, with particular emphasis on post-treatment therapeutic approaches and innovative treatment combinations.
- Post-resection therapeutic strategies
- First-line treatment optimization
- Targeted therapy combinations
Their work extends to developing treatment protocols for both early-stage and advanced colorectal malignancies.
Pancreatic Cancer Treatment
The investigator focuses on advancing treatment options for pancreatic ductal adenocarcinoma, particularly in the post-resection setting.
- Personalized chemotherapy approaches
- Genetic marker-based treatment selection
- Adjuvant therapy optimization
Their research emphasizes the role of genetic markers in treatment selection and outcome improvement.
Precision Oncology
The investigator explores biomarker-driven treatment strategies in gastrointestinal cancers, with particular attention to circulating tumor DNA analysis.
- Molecular-guided therapy
- Personalized treatment selection
- Stage-specific interventions
Their work integrates molecular diagnostics with therapeutic decision-making in early-stage cancer management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.